Succinic semialdehyde dehydrogenase deficiency: A model of neurocircuit imbalances in autism and potential insight into new biomarkers
- PMID: 37302007
- DOI: 10.1111/dmcn.15671
Succinic semialdehyde dehydrogenase deficiency: A model of neurocircuit imbalances in autism and potential insight into new biomarkers
Comment on
-
Autism spectrum disorder and GABA levels in children with succinic semialdehyde dehydrogenase deficiency.Dev Med Child Neurol. 2023 Dec;65(12):1596-1606. doi: 10.1111/dmcn.15659. Epub 2023 May 28. Dev Med Child Neurol. 2023. PMID: 37246331
References
REFERENCES
-
- Maenner MJ, Warren Z, Williams AR, et al. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020. MMWR Surveill Summ 2023; 72: 1-14.
-
- Jensen AR, Lane AL, Werner BA, et al. Modern Biomarkers for Autism Spectrum Disorder: Future Directions. Mol Diagn Ther 2022; 26: 483-95.
-
- Frye RE, Casanova MF, Fatemi SH, et al. Neuropathological Mechanisms of Seizures in Autism Spectrum Disorder. Front Neurosci 2016; 10: 192.
-
- Latzer IT, Hanson E, Bertoldi M, et al. Autism spectrum disorder and GABA levels in children with succinic semihaldehyde dehydrogenase deficiency. Dev Med Child Neurol 2023; 65: 1596-606.
-
- Zhang P, Omanska A, Ander BP, et al. Neuron-specific transcriptomic signatures indicate neuroinflammation and altered neuronal activity in ASD temporal cortex. Proc Natl Acad Sci U S A 2023; 120: e2206758120.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
